DK85183A - Fremgangsmaade til fremstilling af benzokondenserede tricycliske forbindelser eller farmaceutisk acceptable salte deraf og mellemprodukter derved - Google Patents

Fremgangsmaade til fremstilling af benzokondenserede tricycliske forbindelser eller farmaceutisk acceptable salte deraf og mellemprodukter derved

Info

Publication number
DK85183A
DK85183A DK85183A DK85183A DK85183A DK 85183 A DK85183 A DK 85183A DK 85183 A DK85183 A DK 85183A DK 85183 A DK85183 A DK 85183A DK 85183 A DK85183 A DK 85183A
Authority
DK
Denmark
Prior art keywords
benzo
intermediates
procedure
preparation
acceptable salts
Prior art date
Application number
DK85183A
Other languages
Danish (da)
English (en)
Other versions
DK85183D0 (da
Inventor
James Frederick Eggler
Michael Ross Johnson
Jr Lawrence Sherman Melvin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK85183D0 publication Critical patent/DK85183D0/da
Publication of DK85183A publication Critical patent/DK85183A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/33—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups or etherified hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/18—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part
    • C07C33/20—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DK85183A 1982-03-16 1983-02-24 Fremgangsmaade til fremstilling af benzokondenserede tricycliske forbindelser eller farmaceutisk acceptable salte deraf og mellemprodukter derved DK85183A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/358,569 US4476131A (en) 1982-03-16 1982-03-16 Substituted hexahydropyrrolo[1,2-a]-quinolines, hexahydro-1H-pyrido[1,2-a]-q

Publications (2)

Publication Number Publication Date
DK85183D0 DK85183D0 (da) 1983-02-24
DK85183A true DK85183A (da) 1983-09-17

Family

ID=23410189

Family Applications (1)

Application Number Title Priority Date Filing Date
DK85183A DK85183A (da) 1982-03-16 1983-02-24 Fremgangsmaade til fremstilling af benzokondenserede tricycliske forbindelser eller farmaceutisk acceptable salte deraf og mellemprodukter derved

Country Status (27)

Country Link
US (1) US4476131A (ro)
EP (1) EP0090516B1 (ro)
JP (2) JPS58170724A (ro)
KR (2) KR870001126B1 (ro)
AR (1) AR240936A1 (ro)
AT (1) ATE35544T1 (ro)
AU (1) AU543215B2 (ro)
CA (1) CA1254567A (ro)
CS (1) CS249126B2 (ro)
DD (2) DD219765A5 (ro)
DE (1) DE3377280D1 (ro)
DK (1) DK85183A (ro)
ES (2) ES520630A0 (ro)
FI (1) FI76334C (ro)
GR (1) GR77127B (ro)
HU (1) HU189906B (ro)
IE (1) IE54897B1 (ro)
IL (1) IL68131A (ro)
NO (1) NO162385B (ro)
NZ (1) NZ203577A (ro)
PH (1) PH19998A (ro)
PL (2) PL141501B1 (ro)
PT (1) PT76390B (ro)
RO (2) RO88221B (ro)
SU (1) SU1355130A3 (ro)
YU (2) YU44736B (ro)
ZA (1) ZA831781B (ro)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576964A (en) * 1982-03-16 1986-03-18 Pfizer Inc. Substituted hexahydrobenzo[e]indene and octahydrophenanthrene CNS agents and pharmaceutical compositions thereof
US4670562A (en) * 1985-03-13 1987-06-02 Hoechst-Roussel Pharmaceuticals Inc. Dihydropyrrolo[1,2-b]isoquinolinedione oximes
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
CA2187257A1 (en) * 1995-10-12 1997-04-13 Enrique Luis Michelotti Aryl-substituted cycloalkanes and cycloalkenes and herbicidal use thereof
CN1075498C (zh) * 1997-05-08 2001-11-28 车庆明 一种查尔酮c甙和它的用途
US6316734B1 (en) 2000-03-07 2001-11-13 3M Innovative Properties Company Flexible circuits with static discharge protection and process for manufacture
ITGE20080051A1 (it) 2008-06-04 2009-12-05 Matteucci Francesco Metodo per la realizzazione di cavi diamantati rinforzati per il taglio di strutture e materiali in acciaio,calcestruzzo,acciaio e calcestruzzo,materiali litoidi o simili e cavo diamantato rinforzato ottenuto mediante tale metodo.
CN112778241A (zh) * 2021-03-09 2021-05-11 中国科学院兰州化学物理研究所 一种四氢呋喃乙酸及其酯类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3045020A (en) * 1962-07-17 x xcooa
FR1490023A (fr) * 1965-08-17 1967-07-28 Sandoz Sa Dérivés de l'isoquinoléine et leur préparation
US4260764A (en) * 1976-12-22 1981-04-07 Pfizer Inc. 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor
US4188495A (en) * 1977-11-14 1980-02-12 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor

Also Published As

Publication number Publication date
NO162385B (no) 1989-09-11
EP0090516A1 (en) 1983-10-05
KR870001126B1 (ko) 1987-06-09
JPH0260653B2 (ro) 1990-12-17
AU1244883A (en) 1983-09-22
AR240936A1 (es) 1991-03-27
CA1254567A (en) 1989-05-23
IL68131A (en) 1986-07-31
IL68131A0 (en) 1983-06-15
ES8503510A1 (es) 1985-03-01
AU543215B2 (en) 1985-04-04
DE3377280D1 (en) 1988-08-11
GR77127B (ro) 1984-09-07
SU1355130A3 (ru) 1987-11-23
FI830857A0 (fi) 1983-03-15
EP0090516B1 (en) 1988-07-06
YU44736B (en) 1991-02-28
NZ203577A (en) 1985-09-13
PL141640B1 (en) 1987-08-31
JPS63183542A (ja) 1988-07-28
US4476131A (en) 1984-10-09
PL141501B1 (en) 1987-07-31
CS249126B2 (en) 1987-03-12
IE830559L (en) 1983-09-16
YU175785A (en) 1986-08-31
RO85382A (ro) 1984-11-25
PT76390A (en) 1983-04-01
AR240936A2 (es) 1991-03-27
RO88221A (ro) 1985-12-30
FI76334B (fi) 1988-06-30
RO85382B (ro) 1984-11-30
ES527075A0 (es) 1985-04-16
ES520630A0 (es) 1985-03-01
PT76390B (en) 1986-02-03
ZA831781B (en) 1983-11-30
ATE35544T1 (de) 1988-07-15
FI76334C (fi) 1988-10-10
ES8504097A1 (es) 1985-04-16
HUT34146A (en) 1985-02-28
FI830857L (fi) 1983-09-17
KR880006969A (ko) 1988-07-25
HU189906B (en) 1986-08-28
KR840004111A (ko) 1984-10-06
PH19998A (en) 1986-08-28
DD219765A5 (de) 1985-03-13
NO830900L (no) 1983-09-19
PL240989A1 (en) 1984-06-18
RO88221B (ro) 1986-01-02
YU44899B (en) 1991-04-30
IE54897B1 (en) 1990-03-14
YU60683A (en) 1986-04-30
DK85183D0 (da) 1983-02-24
KR880002412B1 (ko) 1988-11-08
PL245846A1 (en) 1984-08-27
DD210270A5 (de) 1984-06-06
JPS58170724A (ja) 1983-10-07

Similar Documents

Publication Publication Date Title
DK301383A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK241883A (da) Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK372283A (da) Fremgangsmaade til fremstilling af desoxyuridinderivater
DK63683D0 (da) Fremgangsmade til fremstilling af cephemderivater
DK323083D0 (da) Fremgangsmade til fremstilling af 19-thio-androstanderivater
DK85183A (da) Fremgangsmaade til fremstilling af benzokondenserede tricycliske forbindelser eller farmaceutisk acceptable salte deraf og mellemprodukter derved
DK427083D0 (da) Fremgangsmade til fremstilling af cephemderivater
DK435483D0 (da) Fremgangsmade til fremstilling af fenylcyklobutylderivater
DK261883D0 (da) Fremgangsmade til fremstilling af prostaglandin-d-derivater
DK162230C (da) Fremgangsmaade til fremstilling af 2-thiacephemderivater
DK426683A (da) Fremgangsmaade til fremstilling af oxacephalosporinderivater
DK317283D0 (da) Fremgangsmade til fremstilling af thiadiazolderivater
DK165983C (da) Fremgangsmaade til fremstilling af phosphorholdige antibiotiske forbindelser betegnet cl 1565-a, cl 1565-b og cl 1565-t eller farmaceutisk acceptable salte deraf
DK386783A (da) Fremgangsmaade til fremstilling af benzamidderivater eller et farmaceutisk acceptabelt salt deraf
DK85683D0 (da) Fremgangsmade til fremstilling af bicycliske kondenserede benzoforbindelser eller farmaceutisk acceptable salte deraf og mellemprodukter ved fremgangsmaden
DK367683D0 (da) Fremgangsmade til fremstilling af n-substituerede 1-oxido-nicotinamider og salte deraf
DK340483D0 (da) Fremgangsmade til fremstilling af fluoralkylerede carbapenemderivater
DK482983D0 (da) Fremgangsmade til fremstilling af phenylderivater
DK165583D0 (da) Fremgangsmade til fremstilling af furanderivater
DK149823C (da) Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf
DK210183D0 (da) Fremgangsmade til fremstillng af piperidinoquinazolin-forbindelser eller farmaceutisk acceptable salte deraf
DK475783D0 (da) Fremgangsmade til fremstilling af farmaceutiske praeparater
DK542383D0 (da) Fremgangsmade til fremstilling af acridanonderivater
DK226883A (da) Fremgangsmaade til fremstilling af trialkylsiliciumholdige phenylcycloalkan-forbindelser eller farmaceutisk acceptable salte deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment